2'-Deoxycytidine-5'-triphosphate (Pubchem)
dNTP Pool
Pool identifier POOL002068
Members of this Pool
Last modified: 10/Sep/2021
Results
Publication
Angulo-Ibáñez M, Rovira-Clavé X, Granados-Jaén A, Downs B, Kim YC, Wang SM, Reina M, Espel E: Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis., Cell Cycle, 2015

PubMed PMCID
Value 0.1434
Dimension fold change
Error Error not provided.
Relative compared to asynchronous control cells
Data presentation in publication diagram
Source
Source organism human (Homo sapiens)
Taxonomy 9606
Sample source cell line
Tissue type T-cell acute lymphoblastic leukemia
CLO Cell line name Jurkat, Clone E6-1 cell (CLO:0007045)
Cell line/type as in publication Jurkat E6.1
Compartment whole cell
Experiment Details
Measurement type dNTP incorporation assay
Extraction method methanol
Remarks to measurement type Mathews and Wheeler
Growth conditions 18 h treatment with 2 mM hydroxyurea
Treatment
Drug/stress type drug
PubChem 3657
Applied drug hydroxyurea
Treatment details/effects MAPK7 (equals Erk5) activity has been associated with cell cycle progression; hydroxyurea (HU) is a ribonucleotide reductase (RNR) inhibitor that causes depletion of dNTP pools
Genes and Proteins
Gene name MAPK7
Gene identifier 5598
Protein name Mitogen-activated protein kinase 7
Protein identifier Q13164
Genetic manipulation/variation silencing